Literature DB >> 23499305

Intrinsic antibiotic resistance: mechanisms, origins, challenges and solutions.

Georgina Cox1, Gerard D Wright.   

Abstract

The intrinsic antibiotic resistome is a naturally occurring phenomenon that predates antibiotic chemotherapy and is present in all bacterial species. In addition to the intrinsic resistance mediated by the bacterial outer membrane and active efflux, studies have shown that a surprising number of additional genes and genetic loci also contribute to this phenotype. Antibiotic resistance is rife in both the clinic and the environment; novel therapeutic strategies need to be developed in order to prevent a major global clinical threat. The possibility of inhibiting elements comprising the intrinsic resistome in bacterial pathogens offers the promise for repurposing existing antibiotics against intrinsically resistant bacteria.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Adjuvant; Antibiotic resistance; Efflux; Gram-negative pathogens; Intrinsic antibiotic resistance; Outer membrane; Permeability; Potentiate; Resistome

Mesh:

Substances:

Year:  2013        PMID: 23499305     DOI: 10.1016/j.ijmm.2013.02.009

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  122 in total

Review 1.  Antibacterial drug discovery in the resistance era.

Authors:  Eric D Brown; Gerard D Wright
Journal:  Nature       Date:  2016-01-21       Impact factor: 49.962

Review 2.  Regulation of antimicrobial resistance by extracytoplasmic function (ECF) sigma factors.

Authors:  Emily C Woods; Shonna M McBride
Journal:  Microbes Infect       Date:  2017-01-30       Impact factor: 2.700

3.  Microbiome changes in healthy volunteers treated with GSK1322322, a novel antibiotic targeting bacterial peptide deformylase.

Authors:  Seda Arat; Aaron Spivak; Stephanie Van Horn; Elizabeth Thomas; Christopher Traini; Ganesh Sathe; George P Livi; Karen Ingraham; Lori Jones; Kelly Aubart; David J Holmes; Odin Naderer; James R Brown
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

Review 4.  Possible drugs for the treatment of bacterial infections in the future: anti-virulence drugs.

Authors:  Hiroshi Ogawara
Journal:  J Antibiot (Tokyo)       Date:  2020-07-09       Impact factor: 2.649

5.  Redefining the essential trafficking pathway for outer membrane lipoproteins.

Authors:  Marcin Grabowicz; Thomas J Silhavy
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-17       Impact factor: 11.205

Review 6.  The antibiotic resistome: gene flow in environments, animals and human beings.

Authors:  Yongfei Hu; George F Gao; Baoli Zhu
Journal:  Front Med       Date:  2017-05-13       Impact factor: 4.592

Review 7.  Emerging evolutionary paradigms in antibiotic discovery.

Authors:  Marc G Chevrette; Cameron R Currie
Journal:  J Ind Microbiol Biotechnol       Date:  2018-09-29       Impact factor: 3.346

8.  Crystal Structure of the N-Acetylmuramic Acid α-1-Phosphate (MurNAc-α1-P) Uridylyltransferase MurU, a Minimal Sugar Nucleotidyltransferase and Potential Drug Target Enzyme in Gram-negative Pathogens.

Authors:  Michaela Renner-Schneck; Isabel Hinderberger; Jonathan Gisin; Thomas Exner; Christoph Mayer; Thilo Stehle
Journal:  J Biol Chem       Date:  2015-03-12       Impact factor: 5.157

9.  Antibacterial activity of and resistance to small molecule inhibitors of the ClpP peptidase.

Authors:  Corey L Compton; Karl R Schmitz; Robert T Sauer; Jason K Sello
Journal:  ACS Chem Biol       Date:  2013-10-04       Impact factor: 5.100

Review 10.  The Evolutionary Conservation of Escherichia coli Drug Efflux Pumps Supports Physiological Functions.

Authors:  Tanisha Teelucksingh; Laura K Thompson; Georgina Cox
Journal:  J Bacteriol       Date:  2020-10-22       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.